Compare TOI & IGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOI | IGD |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.1M | 448.8M |
| IPO Year | N/A | N/A |
| Metric | TOI | IGD |
|---|---|---|
| Price | $3.12 | $5.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 3.1M | 215.3K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.15% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $461,039,000.00 | N/A |
| Revenue This Year | $21.71 | N/A |
| Revenue Next Year | $20.58 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.67 | N/A |
| 52 Week Low | $0.15 | $4.60 |
| 52 Week High | $4.88 | $5.26 |
| Indicator | TOI | IGD |
|---|---|---|
| Relative Strength Index (RSI) | 39.14 | 54.51 |
| Support Level | $2.88 | $5.60 |
| Resistance Level | $3.32 | $5.70 |
| Average True Range (ATR) | 0.35 | 0.06 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 19.12 | 86.96 |
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.